PETDX

Closed

San Diego, United States · Founded 2019 · $72.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Website
petdx.com
Total Funding
$72.0M
Last Round
$62.0M Series BDec 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

PetDx was a San Diego-based veterinary molecular diagnostics company that developed OncoK9, the first and only liquid biopsy multi-cancer early detection (MCED) test for dogs. Founded in 2019, the company used next-generation sequencing (NGS) to detect cancer-associated genomic alterations from a simple blood draw, enabling veterinarians to screen asymptomatic dogs for many types of cancer at scale. PetDx partnered with IDEXX Diagnostics and Antech Diagnostics to expand access to OncoK9, and raised $72 million in total funding including a $62 million Series B in 2021. The company ceased operations in March 2024 due to funding constraints, laying off all employees and halting sample processing.

Summary

PETDX is a Biotech company based in San Diego, United States, founded in 2019. It has raised $72.0M in total across 2 rounds, most recently a $62.0M Series B round in Dec 2021. Investors include Friedman Bioventure.

Funding History

Series BSeries BDec 2021
$62.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PETDX on Indexed.vc
<a href="https://indexed.vc/companies/petdx"><img src="https://indexed.vc/api/badge/company/petdx" alt="PETDX on Indexed.vc" width="260" height="76" /></a>